Riluzole
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
67877-286 -
Package NDC
67877-286-05 -
Package NDC
67877-286-10 -
Package NDC
67877-286-14 -
Package NDC
67877-286-60 -
Package NDC
67877-286-90 -
Application number
ANDA204048 -
SPL ID
ac47b3f7-ac8b-472d-99c6-82b08d7a086f -
SPL set ID
dd432c13-389e-46b3-8891-0cf1a58800ff -
UNII
7LJ087RS6F -
RxCUI
199206
What the source publishes
- Labeler
- Ascend Laboratories, LLC
- Active ingredients
- Riluzole
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Riluzole",
"splId": "ac47b3f7-ac8b-472d-99c6-82b08d7a086f",
"labels": [
{
"setId": "dd432c13-389e-46b3-8891-0cf1a58800ff",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dd432c13-389e-46b3-8891-0cf1a58800ff",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dd432c13-389e-46b3-8891-0cf1a58800ff"
}
],
"routes": [
"ORAL"
],
"labeler": "Ascend Laboratories, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "500 TABLET in 1 BOTTLE (67877-286-05)",
"package_ndc": "67877-286-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20160331"
},
{
"sample": false,
"description": "1000 TABLET in 1 BOTTLE (67877-286-10)",
"package_ndc": "67877-286-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20160331"
},
{
"sample": false,
"description": "10 BLISTER PACK in 1 CARTON (67877-286-14) / 14 TABLET in 1 BLISTER PACK",
"package_ndc": "67877-286-14",
"identifierStatus": "well-formed",
"marketing_start_date": "20160331"
},
{
"sample": false,
"description": "60 TABLET in 1 BOTTLE (67877-286-60)",
"package_ndc": "67877-286-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20160331"
},
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (67877-286-90)",
"package_ndc": "67877-286-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20160331"
}
],
"productId": "67877-286_ac47b3f7-ac8b-472d-99c6-82b08d7a086f",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "67877-286",
"deaSchedule": null,
"genericName": "Riluzole",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "RILUZOLE",
"strength": "50 mg/1"
}
],
"applicationNumber": "ANDA204048",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20160331",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175740",
"M0483511"
],
"upc": [
"0367877286600"
],
"unii": [
"7LJ087RS6F"
],
"rxcui": [
"199206"
],
"spl_set_id": [
"dd432c13-389e-46b3-8891-0cf1a58800ff"
],
"pharm_class_cs": [
"Benzothiazoles [CS]"
],
"pharm_class_epc": [
"Benzothiazole [EPC]"
],
"manufacturer_name": [
"Ascend Laboratories, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:67877-286_ac47b3f7-ac8b-472d-99c6-82b08d7a086f"